Product NDC: | 0472-1627 |
Proprietary Name: | Prometh with Codeine |
Non Proprietary Name: | promethazine hydrochloride and codeine phosphate |
Active Ingredient(s): | 10; 6.25 mg/5mL; mg/5mL & nbsp; promethazine hydrochloride and codeine phosphate |
Administration Route(s): | ORAL |
Dosage Form(s): | SYRUP |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0472-1627 |
Labeler Name: | Actavis Mid Atlantic LLC |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA088763 |
Marketing Category: | ANDA |
Start Marketing Date: | 20030103 |
Package NDC: | 0472-1627-08 |
Package Description: | 237 mL in 1 BOTTLE (0472-1627-08) |
NDC Code | 0472-1627-08 |
Proprietary Name | Prometh with Codeine |
Package Description | 237 mL in 1 BOTTLE (0472-1627-08) |
Product NDC | 0472-1627 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | promethazine hydrochloride and codeine phosphate |
Dosage Form Name | SYRUP |
Route Name | ORAL |
Start Marketing Date | 20030103 |
Marketing Category Name | ANDA |
Labeler Name | Actavis Mid Atlantic LLC |
Substance Name | CODEINE PHOSPHATE; PROMETHAZINE HYDROCHLORIDE |
Strength Number | 10; 6.25 |
Strength Unit | mg/5mL; mg/5mL |
Pharmaceutical Classes | Phenothiazine [EPC],Phenothiazines [Chemical/Ingredient],Full Opioid Agonists [MoA],Opioid Agonist [EPC] |